ALKS vs. FMED
ALKS (Alkermes plc) is a stock, while FMED (Fidelity Disruptive Medicine ETF) is Health & Biotech Equities fund actively managed by Fidelity. Over the past 3 years, ALKS returned 11.28%/yr vs 0.73%/yr for FMED. At a 0.39 correlation, their price movements are largely independent.
Performance
ALKS vs. FMED - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ALKS achieves a 58.54% return, which is significantly higher than FMED's -4.75% return.
ALKS
- 1D
- 0.18%
- 1M
- 18.36%
- YTD
- 58.54%
- 6M
- 57.47%
- 1Y
- 48.71%
- 3Y*
- 11.28%
- 5Y*
- 12.07%
- 10Y*
- 0.70%
FMED
- 1D
- 0.90%
- 1M
- 7.10%
- YTD
- -4.75%
- 6M
- -6.17%
- 1Y
- 8.53%
- 3Y*
- 0.73%
- 5Y*
- —
- 10Y*
- —
ALKS vs. FMED - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
ALKS Alkermes plc | 58.54% | -2.71% | 3.68% | -10.89% |
FMED Fidelity Disruptive Medicine ETF | -4.75% | 9.69% | 2.29% | -3.59% |
Correlation
The correlation between ALKS and FMED is 0.38, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.38 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.39 |
Correlation (All Time) Calculated using the full available price history since Jun 12, 2023 | 0.39 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ALKS vs. FMED — Risk / Return Rank
ALKS
FMED
ALKS vs. FMED - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Alkermes plc (ALKS) and Fidelity Disruptive Medicine ETF (FMED). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ALKS | FMED | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.76 | ||
| Sortino ratioReturn per unit of downside risk | +1.13 | ||
| Omega ratioGain probability vs. loss probability | 1.24 | 1.09 | +0.15 |
| Calmar ratioReturn relative to maximum drawdown | 2.21 | 0.47 | +1.74 |
| Martin ratioReturn relative to average drawdown | 5.11 | 1.03 | +4.08 |
Loading charts...
Drawdowns
ALKS vs. FMED - Drawdown Comparison
The maximum ALKS drawdown since its inception was -96.14%, which is greater than FMED's maximum drawdown of -21.84%. Use the drawdown chart below to compare losses from any high point for ALKS and FMED.
Loading charts...
Drawdown Indicators
| ALKS | FMED | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.14% | -21.84% | -74.30% |
Max Drawdown (1Y)Largest decline over 1 year | -22.20% | -18.33% | -3.87% |
Max Drawdown (3Y)Largest decline over 3 years | -31.58% | -21.84% | -9.74% |
Max Drawdown (5Y)Largest decline over 5 years | -33.18% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -80.58% | — | — |
Current DrawdownCurrent decline from peak | -54.76% | -10.64% | -44.12% |
Average DrawdownAverage peak-to-trough decline | -67.23% | -7.09% | -60.14% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.55% | 8.27% | +1.28% |
Volatility
ALKS vs. FMED - Volatility Comparison
Alkermes plc (ALKS) has a higher volatility of 10.43% compared to Fidelity Disruptive Medicine ETF (FMED) at 7.50%. This indicates that ALKS's price experiences larger fluctuations and is considered to be riskier than FMED based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ALKS | FMED | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.43% | 7.50% | +2.93% |
Volatility (6M)Calculated over the trailing 6-month period | 30.28% | 15.01% | +15.27% |
Volatility (1Y)Calculated over the trailing 1-year period | 40.79% | 19.37% | +21.42% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 37.33% | 18.57% | +18.76% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 41.31% | 18.57% | +22.74% |
Dividends
ALKS vs. FMED - Dividend Comparison
Neither ALKS nor FMED has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 |
|---|---|---|---|
ALKS Alkermes plc | 0.00% | 0.00% | 0.00% |
FMED Fidelity Disruptive Medicine ETF | 0.00% | 0.00% | 0.46% |
Frequently Asked Questions
ALKS and FMED have a correlation of 0.38, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ALKS has higher volatility (10.43%) compared to FMED (7.50%). In terms of maximum drawdown, ALKS dropped -96.14% vs FMED's -21.84%.
ALKS currently has the higher Sharpe Ratio (1.20 vs 0.44), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ALKS and FMED
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer